Package 69097-947-12

{"route": ["ORAL"], "spl_id": "ee5777b3-1606-4a9c-b761-211b47d28522", "openfda": {"unii": ["48A5M73Z4Q"], "rxcui": ["259255", "617310", "617311", "617312"], "spl_set_id": ["18fe5990-399d-416c-852f-e14974317b8b"], "manufacturer_name": ["Cipla USA Inc.,"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "90 TABLET, FILM COATED in 1 BOTTLE (69097-947-05)", "package_ndc": "69097-947-05", "marketing_start_date": "20171116"}, {"sample": false, "description": "500 TABLET, FILM COATED in 1 BOTTLE (69097-947-12)", "package_ndc": "69097-947-12", "marketing_start_date": "20171116"}], "brand_name": "ATORVASTATIN CALCIUM", "product_id": "69097-947_ee5777b3-1606-4a9c-b761-211b47d28522", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["HMG-CoA Reductase Inhibitor [EPC]", "Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]"], "product_ndc": "69097-947", "generic_name": "ATORVASTATIN CALCIUM", "labeler_name": "Cipla USA Inc.,", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "ATORVASTATIN CALCIUM", "active_ingredients": [{"name": "ATORVASTATIN CALCIUM TRIHYDRATE", "strength": "80 mg/1"}], "application_number": "ANDA205519", "marketing_category": "ANDA", "marketing_start_date": "20171116", "listing_expiration_date": "20261231"}